CMed Technologies

Cmed is a technology-led contract research organization (CRO) that provides specialized clinical trial services and advanced data management solutions to the global biopharmaceutical industry. The company is distinguished by its proprietary clinical data suite, Encapsia, which offers a cloud-based environment for real-time data capture, monitoring, and analytics. Cmed focuses on managing complex clinical trials, particularly in high-science areas such as oncology, rare diseases, and cell and gene therapy. In April 2021, Cmed was acquired by Aixial Group, the life sciences division of the Alten Group, to bolster their digital clinical trial capabilities. The integration allows Cmed to leverage a broader global footprint while continuing to innovate in the eClinical technology space.